Valeant Pharma (VRX) Swings to Q3 Loss; Declares $1.00 Special Dividend; Authorizes $1.5B Stock Buyback
Valeant Pharmaceuticals (NYSE: VRX) reports Q3 loss of $1.27, versus $0.25 reported for the same period a year ago. Revenue for the quarter was $208.3 million, which compares to the estimate of $297.08 million.
The company declared a special $1.00 dividend per common share.
The dividend is payable December 22, 2010, to shareholders of record as of the close of business on November 15, 2010. The ex-dividend date is November 11, 2010.
The Board also authorized a $1.5 billion stock buyback program... Read more
VRX
Temporarily unavailable
Source: Yahoo Finance. Stock prices and dividends can be delayed, cached or incomplete.
Older articles featuring VRX:
CenturyLink's Yield Is A Red Flag - Cramer's Lightning Round (9/25/17)Dividends & Income Digest: What Have You Learned From Your Mistakes?
Santa's Gift And State Of High-Yield Market
Retirement Strategy: 5 Pharmaceutical Dividends To Buy Here
Share In Healthcare & Biotech Gains With An 8.3% Yield
Special Dividends Like Never Before
These Dividends Are Nothing Special